| Interferon-λ mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness IE Galani, V Triantafyllia, EE Eleminiadou, O Koltsida, A Stavropoulos, ... Immunity 46 (5), 875-890. e6, 2017 | 486 | 2017 |
| Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison IE Galani, N Rovina, V Lampropoulou, V Triantafyllia, M Manioudaki, ... Nature immunology 22 (1), 32-40, 2021 | 461 | 2021 |
| Natural killer cell accumulation in tumors is dependent on IFN-γ and CXCR3 ligands M Wendel, IE Galani, E Suri-Payer, A Cerwenka Cancer research 68 (20), 8437-8445, 2008 | 423 | 2008 |
| Neutrophils in viral infections: current concepts and caveats IE Galani, E Andreakos Journal of Leucocyte Biology 98 (4), 557-564, 2015 | 233 | 2015 |
| Mononuclear myeloid-derived “suppressor” cells express RAE-1 and activate natural killer cells N Nausch, IE Galani, E Schlecker, A Cerwenka Blood, The Journal of the American Society of Hematology 112 (10), 4080-4089, 2008 | 185 | 2008 |
| Toll-like receptor 7 protects from atherosclerosis by constraining “inflammatory” macrophage activation M Salagianni, IE Galani, AM Lundberg, CH Davos, A Varela, A Gavriil, ... Circulation 126 (8), 952-962, 2012 | 130 | 2012 |
| Inhibition of constitutively activated nuclear factor-κB induces reactive oxygen species-and iron-dependent cell death in cutaneous T-cell lymphoma MK Kiessling, CD Klemke, MM Kamiński, IE Galani, PH Krammer, ... Cancer research 69 (6), 2365-2374, 2009 | 126 | 2009 |
| CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease E Litsiou, M Semitekolou, IE Galani, I Morianos, A Tsoutsa, P Kara, ... American journal of respiratory and critical care medicine 187 (11), 1194-1202, 2013 | 115 | 2013 |
| Interferon lambda1/IL‐29 and inorganic polyphosphate are novel regulators of neutrophil‐driven thromboinflammation A Chrysanthopoulou, K Kambas, D Stakos, I Mitroulis, A Mitsios, V Vidali, ... The Journal of pathology 243 (1), 111-122, 2017 | 109 | 2017 |
| Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control E Andreakos, I Zanoni, IE Galani Current opinion in immunology 56, 67-75, 2019 | 94 | 2019 |
| Interferon-λs: front-line guardians of immunity and homeostasis in the respiratory tract E Andreakos, M Salagianni, IE Galani, O Koltsida Frontiers in immunology 8, 1232, 2017 | 89 | 2017 |
| Treatment of viral conjunctivitis with antiviral drugs CL Skevaki, IE Galani, MV Pararas, KP Giannopoulou, A Tsakris Drugs 71, 331-347, 2011 | 75 | 2011 |
| Type III interferons (IFNs): emerging master regulators of immunity IE Galani, O Koltsida, E Andreakos Crossroads between innate and adaptive immunity V, 1-15, 2015 | 47 | 2015 |
| Antitumor vaccination by Newcastle Disease Virus Hemagglutinin–Neuraminidase plasmid DNA application: Changes in tumor microenvironment and activation of innate anti-tumor immunity J Ni, IE Galani, A Cerwenka, V Schirrmacher, P Fournier Vaccine 29 (6), 1185-1193, 2011 | 35 | 2011 |
| Regulatory T cells control macrophage accumulation and activation in lymphoma IE Galani, M Wendel, A Stojanovic, M Jesiak, MM Müller, C Schellack, ... International journal of cancer 127 (5), 1131-1140, 2010 | 34 | 2010 |
| TFEB signaling attenuates NLRP3‐driven inflammatory responses in severe asthma E Theofani, M Semitekolou, K Samitas, A Mais, IE Galani, V Triantafyllia, ... Allergy 77 (7), 2131-2146, 2022 | 28 | 2022 |
| Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities IE Galani, E Andreakos Seminars in immunology 55, 101522, 2021 | 15 | 2021 |
| Protocol for influenza A virus infection of mice and viral load determination IE Galani, V Triantafyllia, EE Eleminiadou, E Andreakos STAR protocols 3 (1), 101151, 2022 | 11 | 2022 |
| CD103 integrin identifies a high IL‐10‐producing FoxP3+ regulatory T cell population suppressing allergic airway inflammation S Tagkareli, M Salagianni, IE Galani, M Manioudaki, E Pavlos, ... Allergy, 2021 | 8 | 2021 |
| Severity of neonatal influenza infection is driven by type I interferon and oxidative stress OK Kumova, IE Galani, A Rao, H Johnson, V Triantafyllia, SM Matt, ... Mucosal immunology 15 (6), 1309-1320, 2022 | 4 | 2022 |
